Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ML Strategies is a private government relations and strategic consulting firm affiliated with Mintz that advises clients at the federal, state, and local levels. The firm is not a drug developer, biotech, or pharmaceutical manufacturer; instead, it supports companies and organizations on policy, lobbying, regulatory, reimbursement, and market-access issues. Within healthcare and life sciences, ML Strategies works with innovators and industry groups on congressional, FDA, CMS, and state-level policy matters, including medtech, healthcare delivery, and broader life sciences issues. Its business is services-based rather than product-based, so it does not maintain a therapeutic pipeline. For a biotech analyst, ML Strategies is best understood as a healthcare and life sciences policy advisor rather than an operating therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ML Strategies.